ADD ANI AS A TRUSTED SOURCE
googleads
Menu
Business

Why India is Turning to Exosome Therapy for Hair Growth - Science Behind It

New Delhi [India], January 23: In a significant leap forward for hair and skin wellness, VCare has introduced exosome Therapy, bringing this groundbreaking, autologous treatment to India for the very first time. ExoGro, an advanced Exosome Therapy for Hair Loss concerns, deriving potent growth factors, proteins and messenger RNAs from patients' own cells without the interference of any other foreign object or chemical, is the highlight of this treatment.

ANI Jan 23, 2025 12:05 IST googleads

Why India is Turning to Exosome Therapy for Hair Growth – Science Behind It

VMPL
New Delhi [India], January 23: In a significant leap forward for hair and skin wellness, VCare has introduced exosome Therapy, bringing this groundbreaking, autologous treatment to India for the very first time. ExoGro, an advanced Exosome Therapy for Hair Loss concerns, deriving potent growth factors, proteins and messenger RNAs from patients' own cells without the interference of any other foreign object or chemical, is the highlight of this treatment.
As hair thinning, baldness, and premature aging continue to be widespread concerns, Exosome Therapy emerges as a transformative option. With India's aesthetic industry evolving rapidly, VCare's adoption of this cutting-edge technology underscores its leadership in trichology and dermatology.
What is Exogro Therapy - Exosome Treatment for Hair Loss
VCare's Exogro Hair Treatment utilizes exosomes, tiny extracellular vesicles naturally present in the body that function as powerful cell messengers. These exosomes are derived from the patient's own cells, making the treatment entirely autologous and safe. Packed with growth factors, proteins, and genetic materials, exosomes promote cellular repair, regeneration, and rejuvenation.
Unlike traditional therapies, Exosome Therapy delivers a concentrated solution directly to the problem areas, triggering faster and more efficient hair follicle repair and collagen production.
Process of VCare's ExoGro Treatment? Discover What Happens in Just 45 Minutes!
A small blood sample is drawn in a quick, painless process. Using cutting-edge centrifugation and VCare's revolutionary Ultra-Filtration process, the exosomes are isolated and purified, creating a highly concentrated solution. The exosomes are injected into targeted areas like thinning hairlines, bald spots, or dull skin. The solution gets to work immediately, repairing and regenerating cells at the source. The entire procedure takes just 45 minutes, with minimal downtime, so you can get back to your daily routine immediately.
Why ExoGro is the Next Big Thing in Hair Science?
* Next-Gen Growth Factors: Delivers significantly more growth factors than PRP for faster hair follicle activation.
* Fewer Sessions, Faster Results: Results of this VCare's Exosome treatment were noticed in as low as 14 days.
* Completely Non-Surgical: ExoGro is minimally invasive and pain-free, unlike transplants or invasive hair treatments.
* 100% Absorption: Advanced micro-needling ensures maximum penetration of exosomes into the scalp.
* Zero Downtime: Patients experience little to no recovery time
Setting New Standards in India's Aesthetic Wellness Industry
With the introduction of Exosome Therapy, VCare continues to set benchmarks in innovation, accessibility, and personalized care. South India's leading hair and skin clinic, trusted by over 1.5 million clients, ensures this advanced treatment is available across its 70+ clinics, spanning Tamil Nadu, Goa Karnataka, Andhra Pradesh, Pondicherry, and Telangana.
Led by the vision of India's leading trichologist, Carolin Praba Reddy - Chairperson of VCare, the brand has consistently raised the bar for excellence in trichology and dermatology.
Who Can Benefit from Exogro?
ExoGro is ideal for:
* Early-stage thinning or hair loss.
* Male Pattern Baldness.
* Stress-induced hair shedding or hormonal hair loss.
* Symptoms of Alopecia Areata.
* Anyone seeking a non-surgical solution for hair regrowth.
Those interested are invited to take advantage of a free consultation, where experts guide them through the benefits and expected outcomes of Exosome Therapy.
For more information or to schedule your consultation, contact VCare at: +91 8220907070
(ADVERTORIAL DISCLAIMER: The above press release has been provided by VMPL. ANI will not be responsible in any way for the content of the same)

Get the App

What to Read Next

Business

NBC Bearings Unveils New Product Range for Construction Equipment

NBC Bearings Unveils New Product Range for Construction Equipment

Greater Noida (Uttar Pradesh) [India], September 17: NBC Bearings, the flagship brand of National Engineering Industries Ltd. (NEI) and part of of the multi-billion-dollar CKA Birla Group today unveiled a new range of bearings for construction and off-highway equipment at bauma CONEXPO INDIA 2026, strengthening its presence in one of India’s rapidly evolving industrial segments.

Read More
Business

HarvestPlus Solutions Announces Ravinder Grover as CEO

HarvestPlus Solutions Announces Ravinder Grover as CEO

New Delhi [India], September 17: The Board of Directors of HarvestPlus Solutions has unanimously elected Ravinder Grover as Chief Executive Officer, effective September 15, 2026, succeeding Arun Baral, who is retiring for health reasons after seven years of outstanding leadership.

Read More
Business

FundedSmart Brings Structured Simulated Trading Evaluations

FundedSmart Brings Structured Simulated Trading Evaluations

Dubai [UAE] / New Delhi [India],September 17: FundedSmart, the trading skill development platform of Upward Trading FZCO, Dubai, UAE, has launched the trading ability assessments that are structured and simulated to help the participants get a feel of the Indian markets.

Read More
Business

Medicover Hospitals Bengaluru treats rare Mirizzi syndrome

Medicover Hospitals Bengaluru treats rare Mirizzi syndrome

Bengaluru (Karnataka) [India], September 17: Surgeons at Medicover Hospitals, Hoodi, Bengaluru, have treated a 54-year-old man with severe obstructive jaundice who had been advised elsewhere that he most likely had a cancerous tumour near the bile duct. The actual cause turned out to be Type 1 Mirizzi syndrome, a rare condition in which gallstones compress the main bile duct from outside, complicated by a pus-filled gallbladder.

Read More
Business

Continental Securities Rallies Toward 52-Week High as NBFC Sector

Continental Securities Rallies Toward 52-Week High as NBFC Sector

New Delhi [India], September 17: Shares of Continental Securities Ltd (BSE: 538868) have emerged as a strong breakout candidate, trading near Rs 23.60 and closing in on its 52-week high of Rs 24.80 hit on September 11. The stock is up 58.07% year-to-date and has gained nearly 50% in the last one month, backed by a sharp surge in volumes.

Read More
Home About Us Our Products Advertise Contact Us Terms & Condition Privacy Policy

Copyright © aninews.in | All Rights Reserved.